BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31133634)

  • 21. Low-molecular-weight heparin-induced thrombocytopenia in a child.
    Dager WE; White RH
    Ann Pharmacother; 2004 Feb; 38(2):247-50. PubMed ID: 14742760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
    Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe thrombocytopenia after heparin therapy in a patient with unstable angina and recent stent implantation.
    Sideris SK; Bonios MJ; Eftihiadis EE; Melexopoulou CA; Mousiama TA; Diplaris KT; Kogias JS
    Hellenic J Cardiol; 2005; 46(3):242-6. PubMed ID: 15981562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
    Seculini Patiño CE; Pascualini MF; Tabares AH
    Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heparin-Induced Thrombocytopenia after Total Knee Replacement].
    Salášek M; Šlechtová J; Pavelk T
    Acta Chir Orthop Traumatol Cech; 2020; 87(2):129-133. PubMed ID: 32396515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
    Jiji RS; Michaels AD
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):819-22. PubMed ID: 18798244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
    Alving BM; Krishnamurti C
    Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of heparin-induced thrombocytopenia].
    Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
    Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
    Ban-Hoefen M; Francis C
    Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An infrequent complication of a not so infrequent disease. Hit by HIT.
    Sandoval E; Ascaso M; Quintana E; Pereda D
    Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):124-126. PubMed ID: 30011999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors.
    Bangalore S; Toklu B; Kotwal A; Volodarskiy A; Sharma S; Kirtane AJ; Feit F
    BMJ; 2014 Nov; 349():g6419. PubMed ID: 25389143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of ST elevation myocardial infarction secondary to heparin-induced thrombocytopaenia with thrombosis.
    Arnott C; Wilcox I; Patel S
    Heart Lung Circ; 2012 Dec; 21(12):841-3. PubMed ID: 22695183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Arterial thrombosis due to heparin induced thrombocytopenia].
    Klinkert LC; van Leeuwen DG; Brouwers AJ; van der Klooster JM
    Ned Tijdschr Geneeskd; 2013; 157(39):A6237. PubMed ID: 24063671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial and venous complications of heparin-induced thrombocytopenia in burn patients.
    Scott JR; Klein MB; Gernsheimer T; Honari S; Gibbons J; Gibran NS
    J Burn Care Res; 2007; 28(1):71-5. PubMed ID: 17211203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.